Qlaris Phase 2 Study of QLS-111 in POAG And/or OHT Patients

Clinical trial NCT06016972 · COMPLETED

Trial details

NCT number: NCT06016972
Sponsor: Qlaris Bio, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Open Angle Glaucoma (POAG)Primary Open Angle Glaucoma of Both Eyes Primary Open-Angle Glaucoma, Unspecified Eye Ocular Hypertension (OHT)

Start date: 2024-03-05
Primary completion: 2024-08-20
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.